183 related articles for article (PubMed ID: 7546194)
1. The role of IL-12 in the induction of organ-specific autoimmune diseases.
Trembleau S; Germann T; Gately MK; Adorini L
Immunol Today; 1995 Aug; 16(8):383-6. PubMed ID: 7546194
[TBL] [Abstract][Full Text] [Related]
2. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes.
Trembleau S; Penna G; Gregori S; Gately MK; Adorini L
Eur J Immunol; 1997 Sep; 27(9):2330-9. PubMed ID: 9341777
[TBL] [Abstract][Full Text] [Related]
3. T-cell regulation in murine and human autoimmune diabetes: the role of TH1 and TH2 cells.
Heurtier AH; Boitard C
Diabetes Metab; 1997 Nov; 23(5):377-85. PubMed ID: 9416429
[TBL] [Abstract][Full Text] [Related]
4. IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetes.
Joseph J; Bittner S; Kaiser FM; Wiendl H; Kissler S
J Immunol; 2012 Jan; 188(1):216-21. PubMed ID: 22116823
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis.
Constantinescu CS; Wysocka M; Hilliard B; Ventura ES; Lavi E; Trinchieri G; Rostami A
J Immunol; 1998 Nov; 161(9):5097-104. PubMed ID: 9794448
[TBL] [Abstract][Full Text] [Related]
6. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
[TBL] [Abstract][Full Text] [Related]
7. Immunopathogenic role of TH1 cells in autoimmune diabetes: evidence from a T1 and T2 doubly transgenic non-obese diabetic mouse model.
Hung JT; Liao JH; Lin YC; Chang HY; Wu SF; Chang TH; Kung JT; Hsieh SL; McDevitt H; Sytwu HK
J Autoimmun; 2005 Nov; 25(3):181-92. PubMed ID: 16263243
[TBL] [Abstract][Full Text] [Related]
8. Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline.
Bright JJ; Du C; Coon M; Sriram S; Klaus SJ
J Immunol; 1998 Dec; 161(12):7015-22. PubMed ID: 9862738
[TBL] [Abstract][Full Text] [Related]
9. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.
Toyoda H; Formby B
Bioessays; 1998 Sep; 20(9):750-7. PubMed ID: 9819564
[TBL] [Abstract][Full Text] [Related]
10. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis.
Xu H; Rizzo LV; Silver PB; Caspi RR
Cell Immunol; 1997 May; 178(1):69-78. PubMed ID: 9184700
[TBL] [Abstract][Full Text] [Related]
11. Different TH2-TH1 balance in V beta 8 and V beta 6 subsets of splenocytes in NOD females in the early phase of diabetogenesis.
Atlan-Gepner C; Hermitte L; Janand-Delenne B; Naquet P; Vialettes B
Diabetes Metab; 1997 Nov; 23(5):386-94. PubMed ID: 9416430
[TBL] [Abstract][Full Text] [Related]
12. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.
Liblau RS; Singer SM; McDevitt HO
Immunol Today; 1995 Jan; 16(1):34-8. PubMed ID: 7880387
[TBL] [Abstract][Full Text] [Related]
13. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function.
Cua DJ; Coffman RL; Stohlman SA
J Immunol; 1996 Oct; 157(7):2830-6. PubMed ID: 8816386
[TBL] [Abstract][Full Text] [Related]
14. SJL and NOD macrophages are uniquely characterized by genetically programmed, elevated expression of the IL-12(p40) gene, suggesting a conserved pathway for the induction of organ-specific autoimmunity.
Alleva DG; Johnson EB; Wilson J; Beller DI; Conlon PJ
J Leukoc Biol; 2001 Mar; 69(3):440-8. PubMed ID: 11261792
[TBL] [Abstract][Full Text] [Related]
15. Modeling the influence of TH1- and TH2-type cells in autoimmune diseases.
Louzoun Y; Atlan H; Cohen IR
J Autoimmun; 2001 Dec; 17(4):311-21. PubMed ID: 11771956
[TBL] [Abstract][Full Text] [Related]
16. Th1 development of naive CD4+ T cells is inhibited by co-activation with anti-CD4 monoclonal antibodies.
Goedert S; Germann T; Hoehn P; Koelsch S; Palm N; Rüde E; Schmitt E
J Immunol; 1996 Jul; 157(2):566-73. PubMed ID: 8752903
[TBL] [Abstract][Full Text] [Related]
17. IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic Islets.
Falcone M; Yeung B; Tucker L; Rodriguez E; Krahl T; Sarvetnick N
Clin Immunol; 2001 Feb; 98(2):190-9. PubMed ID: 11161975
[TBL] [Abstract][Full Text] [Related]
18. The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes.
Balasa B; Sarvetnick N
J Autoimmun; 1996 Apr; 9(2):283-6. PubMed ID: 8738975
[TBL] [Abstract][Full Text] [Related]
19. The role of helper T cell subsets in autoimmune diseases.
Lafaille JJ
Cytokine Growth Factor Rev; 1998 Jun; 9(2):139-51. PubMed ID: 9754708
[TBL] [Abstract][Full Text] [Related]
20. Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.
Ross SE; Williams RO; Mason LJ; Mauri C; Marinova-Mutafchieva L; Malfait AM; Maini RN; Feldmann M
J Immunol; 1997 Dec; 159(12):6253-9. PubMed ID: 9550429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
